NICE does not recommend AbbVie’s leukaemia drug
16 February 2017 | By Niamh Marriott, Digital Editor
The incremental cost-effectiveness ratios (ICERs) for venetoclax compared with best supportive care were higher than the normally range...
List view / Grid view
News
SOPHiA AI becomes the technology of choice for clinical diagnostic in Latin America
16 February 2017 | By Niamh Marriott, Digital Editor
Sophia Genetics announced that ten new genomic institutions from Latin America have started using SOPHiA to democratise access to clinical genomics...
NICE approves Incyte’s leukaemia drug for routine NHS use
13 February 2017 | By Niamh Marriott, Digital Editor
NICE published draft guidance recommending ponatinib (Iclusig, Incyte Corporation) for routine use on the NHS, to treat chronic myeloid leukaemia...
1000 patient Phase III study required for Armetheon before FDA approval
10 February 2017 | By Niamh Marriott, Digital Editor
Armetheon has reached agreement with the FDA for a single 1000 patient final pivotal trial for its drug candidate, tecarfarin, prior to filing an NDA...
Amgen vs. Sanofi – appeals court suspend patent injunction
9 February 2017 | By Niamh Marriott, Digital Editor
"It is our longstanding position that Amgen's asserted patent claims are invalid and we look forward to moving forward with the appeal process."
Keele researchers create biosensor to better diagnose stroke
8 February 2017 | By Niamh Marriott, Digital Editor
Keele University stroke specialist Professor Christine Roffe is leading ground breaking clinical trials into a smart chip that could save lives.
NICE recommends targeted breast cancer radiotherapy treatment
8 February 2017 | By Niamh Marriott, Digital Editor
NICE has today published draft guidance recommending the Intrabeam Radiotherapy System (Carl Zeiss UK) for people with early breast cancer...
Nanobiotix appoints Oncology industry veteran as Chief Operating Officer
7 February 2017 | By Niamh Marriott, Digital Editor
Nanobiotix, a late clinical-stage nanomedicine company, announced the appointment of Alain Dostie, a senior executive from the pharmaceutical industry, as its Chief Operating Officer. Mr Dostie will lead Nanobiotix’s operations, including development, manufacturing, market access and sales, for their lead product NBTXR3, which could obtain a CE Mark approval in…
NIR spectroscopy for monitoring of industrial manufacturing processes
7 February 2017 | By Metrohm Appllikon
When it comes to monitoring industrial manufacturing processes, NIRS offers a rapid and reliable supplement to conventional titration methods...
Smaller and faster: Mira M-3 handheld Raman spectrometer for material verification
6 February 2017 | By Metrohm
The Mira M-3 is the new handheld Raman spectrometer from Metrohm. Barely larger than a smartphone, the Mira M-3 enables true single-handed operation...
FDA approves Abbott’s molecular Zika virus test
3 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorised to detect Zika in whole blood samples;…
Pfizer’s breast cancer drug too expensive for NHS
3 February 2017 | By Niamh Marriott, Digital Editor
NICE has today published draft guidance which does not recommend Pfizer's breast cancer drug palbociclib for routine funding on the NHS...
Immunotherapy treatment fast-tracked under UK’s access to medicines scheme
2 February 2017 | By Niamh Marriott, Digital Editor
From today, UK patients with an incurable form of bladder cancer can access the new immunotherapy, atezolizumab, following a positive Scientific Opinion...
Linkam launches the CMS196M for enhanced Cryo-correlative Microscopy with greatly improved work flow
Linkam Scientific Instruments, announce the launch of the CMS196M for enhanced Cryo Correlative Microscopy with greatly improved work flow...
7th Annual Strategic Alliance Management for Pharma
25 January 2017 | By marcus evans
This marcus evans forum will help delegates to structure the Alliance management internally as well as to offer an insight on the responsibilities and roles of the Alliance function...
